Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbinafin HBF cream vs Lamisil cream in interdigital tinea pedis
2005-000940-10Phase 3Completed
- Sponsor
- APIGENEX s.r.o.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Terbinafine in Athlete's foot (2 arms), sponsored by APIGENEX s.r.o. Primary endpoint: Clinical cure without adverse drug reactions. Started May 2005; status: completed.
02
Drugs
Terbinafine
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on 2005-000940-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000940-10.